GlassScriptPhysician profile
Jeffanne Millien
NPI 1245658079
$7,530.90
in general payments reported to CMS, 2019-2025
14 companies · $27.81 in 2025
The $27.81 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $208 · 2022: $334 · 2023: $63.56 · 2024: $6,651 · 2025: $27.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,228 · Travel and Lodging: $2,124 · Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,228.21 |
| Travel and Lodging | $2,123.79 |
| Food and Beverage | $390.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,676.14 | 2022-2024 | |
| La Jolla Pharmaceutical Company | $212.21 | 2022-2023 | Giapreza |
| Abbott Laboratories | $110.93 | 2019 | |
| Portola Pharmaceuticals, LLC | $100.19 | 2020 | |
| Merck Sharp & Dohme LLC | $85.88 | 2019-2020 | |
| Ethicon US, LLC | $74.79 | 2024 | Surgicel Nu-Knit |
| Davol INC. | $53.73 | 2022 | |
| Csl Behring | $44.74 | 2019-2020 | |
| Pfizer INC. | $41.18 | 2019 | |
| Allergan, INC. | $38.09 | 2019 | |
| Organogenesis INC. | $31.14 | 2023 | Puraply |
| Medtronic, INC. | $27.81 | 2025 | Transorb |
| Livanova USA, INC. | $18.74 | 2020 | |
| Acera Surgical, INC. | $15.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffanne Millien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.